Compare BTOC & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTOC | NOTV |
|---|---|---|
| Founded | 2020 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6M | 29.9M |
| IPO Year | 2024 | 1997 |
| Metric | BTOC | NOTV |
|---|---|---|
| Price | $0.64 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 430.0K | ★ 1.6M |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $197,399,541.00 | ★ $513,024,000.00 |
| Revenue This Year | $34.89 | $6.26 |
| Revenue Next Year | $14.53 | $45.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.35 | 4.54 |
| 52 Week Low | $0.41 | $0.66 |
| 52 Week High | $5.84 | $6.48 |
| Indicator | BTOC | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 30.65 |
| Support Level | $0.56 | $0.79 |
| Resistance Level | $0.72 | $0.86 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 54.01 | 6.69 |
Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.